Search results
DOAC-Remove™50
Removes DOACs and argatroban from citrated plasmas thereby reducing interference when the plasma is tested in laboratory coagulation assays such as aPTT, TT, single factors, lupus AC, and APC-R.
DOAC-Remove™20
Removes DOACs and argatroban from citrated plasmas thereby reducing interference when the plasma is tested in laboratory coagulation assays such as aPTT, TT, single factors, lupus AC, and APC-R.
5-BUFFER USP/Ph.Eur. Tris-NaCl-EDTA-PEG-6000 Buffer salts pH 8.4
5-BUFFER USP/Ph.Eur. Tris-NaCI-EDTA-PEG-6000 Buffer salts, pH 8.4 for the quality control of the anti-FXa and anti-FIIa activity of UFH in compliance with European Pharmacopoeia or with US Pharmacopoeia.
5-BUFFER USP/Ph.Eur. Tris-NaCl-BSA Buffer salts pH 7.4
5-BUFFER USP/Ph.Eur. Tris-NaCI-BSA Buffer salts, pH 7.4 for the quality control of the anti-FXa and anti-FIIa activity of LMWH in compliance with European Pharmacopoeia.
5-BUFFER USP Tris-NaCl-PEG-6000 Buffer salts pH 7.4
5-BUFFER USP Tris-NaCl-PEG-6000 Buffer salts, pH 7.4 for the quality control of the anti-FXa and anti-FIIa activity of LMWH in compliance with US Pharmacopoeia.
5-BUFFER USP/Ph.Eur. Tris-NaCl-EDTA Buffer salts pH 8.4
5-BUFFER USP/Ph.Eur. Tris-NaCI-EDTA Buffer salts, pH 8.4 for the quality control of anti-FXa and anti-FIIa activity of LMWH in compliance with European Pharmacopoeia or with US Pharmacopoeia.
5-BUFFER USP Tris-NaCl Buffer salts pH 7.4
5-BUFFER USP Tris-NaCl Buffer salts, pH 7.4 for the quality control of the anti-FXa and anti-FIIa activity of LMWH in compliance with US Pharmacopoeia.
HEPA-Remove®
Heparin and heparin-like molecules interfere with various assays including coagulation assays and PCR-based assays. HEPA-Remove®has been designed to eliminate these interferences. Moreover, HEPA-Remove®inhibits FXII activation in aPTT based assays. For research use only.
5-ENZYME Convulxin
Studies on platelet receptors. MW: 84 kDa non-reduced, 14 and 16 kDa double band on reduction.
Aprotinin
Aprotinin can be used in any application where inhibition of its targeted proteases is needed. Current uses include protein isolation, removal of reactive proteases through solid phase, inhibition of undesired proteolytic activity in laboratory assays, or other techniques; for blocking fibrinolytic activity in vitro; etc.